Tradestie Institutional Equity Comparison Engine

FOLD vs AVDL โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-04-24 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AVDL Overall Edge

AVDL Captures Institutional Edge (3โ€“1 Pillars ยท 5โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Avadel Pharmaceuticals plc Ordinary Share (AVDL) driven by superior Valuation, Growth & Margin, Momentum & Technical while FOLD counters with relative strength in Options & Structure. Fundamentally, FOLD trades at 17.7x Forward P/E with 8.6% operating margin (+23.7% YoY revenue) versus AVDL at 28.8x Forward P/E and 2.5% operating margin (+54.9% YoY). In options structure, FOLD sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against AVDL sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner AVDL
FOLD 17.7x vs AVDL 28.8x Fwd P/E
Growth & Margin Winner AVDL
Op Margin 8.6% vs 2.5% ยท YoY +23.7% vs +54.9%
Momentum & Technical Winner AVDL
1Y +104.1% vs +138.1% ยท 52W Pos 100% vs 89%
Options & Structure Winner FOLD
UNCLASSIFIED (<1st %ile IV) vs UNCLASSIFIED (<1st %ile IV)
FOLD NASDAQ
Amicus Therapeutics, Inc
Pharmaceutical Preparations
$14.49
+0.21% 1D
Market Cap $4.5B
1M Return +0.42%
1Y Return +104.08%
Forward P/E 17.7x
Unified AI Score
59.4 / 100 HOLD
Tech 40.0 Fund 52.0 Flow 71.0 Mom 46.0
AVDL NASDAQ
Avadel Pharmaceuticals plc Ordinary Share
Pharmaceutical Preparations
$21.64
+0.05% 1D
Market Cap $2.1B
1M Return +0.65%
1Y Return +138.06%
Forward P/E 28.8x
Unified AI Score
62.9 / 100 BUY
Tech 75.0 Fund 60.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: FOLD +104.08% AVDL +138.06% Spread: +58.86 pp (AVDL Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
FOLD TTM Op. Margin: 8.6% AVDL TTM Op. Margin: 2.5%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on FOLD vs AVDL. Trailing 12-month operating profitability (FOLD 8.6% vs AVDL 2.5%) and valuation multiples (FOLD 17.7x vs AVDL 28.8x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: FOLD (5) vs AVDL (5)
Institutional Metric FOLD AVDL Criterion Row Winner
Market Capitalization Scale $4.5B $2.1B Larger Scale FOLD
Trailing P/E Ratio Valuation 30.5x 16.8x Lower Multiple AVDL
Forward P/E Ratio Valuation 17.7x 28.8x Lower Multiple FOLD
Revenue Growth (YoY) Growth +23.7% +54.9% Higher Growth AVDL
Operating Margin (TTM) Profitability 8.6% 2.5% Higher Margin FOLD
Net Profit Margin Profitability -4.3% -0.1% Higher Margin AVDL
Return on Equity (ROE) Capital Efficiency -11.6% -0.3% Higher ROE AVDL
52-Week Range Position Momentum 100% ($6โ€“$14) 89% ($6โ€“$24) Stronger Trend FOLD
Beta / 30D Volatility Risk Regime 0.27ฮฒ ยท 2% Vol 0.14ฮฒ ยท 2% Vol Lower Realized Risk FOLD
Unified Institutional Score Composite Signal 59.4 / 100 (HOLD) 62.9 / 100 (BUY) Higher Composite AVDL

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full FOLD vs AVDL Buy Guide
FOLD UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live FOLD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
AVDL UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live AVDL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither FOLD nor AVDL registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.